BTG Pactual hires Charles Rosier for European business
He has been an excellent investment banker for a period of 15 years. charles rosier (http://www.efinancialnews.com/story/2010-09-17/charles-rosier-joins-btg) managed the French-speaking markets of France, Belgium and Quebec. In 1999, Goldman Sachs offered Charles Rosier a job. He accepted the offer and joined as their Managing Director.
Charles Rosier helped by financing MPOWERD to develop lanterns and other effective energy solutions. As a result, over 25 poor countries all around the planet have been supplied by MPOWERD. For poor countries to have cost-effective energy solutions, MPOWERD developed LED lanterns. Charles Rosier is truly dedicated to helping the environment by developing energy and power sectors in poor countries. Promoting the proper use of resources paired with awareness projects on pollution-free environment is crucial to Innoveox since they envision creating a secure environment for all by reducing carbon dioxide emissions.
Educational Achievements of Charles Rosier
Gaining his scientific Baccalaureate degree (similar to A-levels in the UK), Charles Rosier was able to attend to further education. He went to Lehman Brothers in 1996 and eventually became a member of UBS Warburg Investment Bank. In order to achieve more French qualifications, Charles Rosier took two years of additional classes in preparation.
Charles Rosier's Job Experience
As a partner at BTG Pactual Bank, he got the chance to work with a popular institution with 30 years of experience, appointing more than 2,500 workers in different areas in Latin America. Charles Rosier became the Managing Director of Goldman Sachs, from 2009 to 2010. Five principles (Customer Focus, Long Term View, Global Thinking Presence, Meritocracy and Partnership and World-Class Governance) were set by him during his stay at BTG Pactual. Charles Rosier worked at SBC Warburg as their Debt Capital Manager from 1997-2009. He also became an investment banker at Lehman Brothers, which marked the launching of his profession.
Charles Rosier: Successful Healthcare Projects
Charles Rosier was the major investor of the project, for which a drug was being tested to treat stroke that causes damage to the spinal cord. The Mapreg Drug project was Charles Rosier’s first healthcare project. Because of the capital he invested, the study on depression, strokes and other serious illnesses was conducted at Mapreg, a Paris-based laboratory.